SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-070883
Filing Date
2024-06-12
Accepted
2024-06-12 16:36:52
Documents
1
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417108-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417108-4_4seq1.xml 4 3081
  Complete submission text file 0001104659-24-070883.txt   4639
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Issuer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 7707 FANNIN ST SUITE 140 HOUSTON TX 77054
Business Address
Misajon Pamela (Reporting) CIK: 0001987857 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39619 | Film No.: 241038898